Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DC9444 5-R-Rivaroxaban

5-R-Rivaroxaban is (R) enantiomer of Rivaroxaban.

865479-71-6
DC20195 6-(Dimethylamino)purine;N,N-Dimethyladenine

6-Dimethylaminopurine is a serine threonine protein kinase inhibitor. It inhibits the germinal vesicle breakdown and the meiotic maturation of oocytes.

938-55-6
DC23336 6-Ethylthioinosine

6-Ethylthioinosine (6-ETI.

13286-04-9
DC20604 6-FABA

6-FABA (6-Fluoroanthranilic Acid) is a small-molecule inhibitor of MTB tryptophan synthesis that converts Mtb into a tryptophan auxotroph and restores the efficacy of a failed host defense.

434-76-4
DC9376 6-FITC

6-Fluorescein isothiocyanate(6-FITC) is a derivative of fluorescein used in wide-ranging applications including flow cytometry.

3326-31-6
DC12326 6-Hydroxybentazon (6-Hydroxybentazone)

6-Hydroxybentazon is a phase I metabolite of bentazone, and bentazone is a chemical for use in herbicides.

60374-42-7
DC20297 6-Hydroxy-DL-DOPA Featured

6-Hydroxy-DL-DOPA is a small-molecule that disrupts with RAD52 oligomerization, inhibits ssDNA binding by RAD52 with IC50 of 1.1 uM and by RAD52 (1 209) with IC50 of 1.6 uM.

21373-30-8
DC8864 6-Mercaptopurine (6-MP) Monohydrate

6-Mercaptopurine Monohydrate is a widely used antileukemic agent and immunosuppressive drug that inhibits de novo purine synthesis through incorporation of thiopurine methyltransferase metabolites into DNA and RNA.

6112-76-1
DC12540 6-MOMIPP

6-MOMIPP is a novel microtubule disruptor that targets the colchicine binding site on β-tubulin, induces mitotic arrest, caspase activation and loss of cell viability of U251 glioblastoma in vitro.

1961272-45-6
DC10215 7,8-Dihydroxyflavone

7,8-Dihydroxyflavone acts as a potent and selective small-molecule agonist of the TrkB receptor (Kd ≈ 320 nM), the main signaling receptor of brain-derived neurotrophic factor (BDNF).

38183-03-8
DC12463 7-BIA

7-BIA is a small molecule 7-butoxy illudalic acid analog that targets receptor-type protein tyrosine phosphatase D (PTPRD, IC50=1-3 uM) with some specificity.

1313403-49-4
DC12215 7-Dehydrocholesterol

7-Dehydrocholesterol is biosynthetic precursor of cholesterol and vitamin D3.

434-16-2
DC21513 7DG

7DG (7-Desacetoxy-6,7-dehydrogedunin) is a selective inhibitor of protein kinase R (PKR) that directly interact with the C-terminal of PKR.

26927-01-5
DC26033 8-Hydroxy-efavirenz Featured

8-Hydroxy-efavirenz is the primary metabolite of the antiretroviral drug Efavirenz, stimulates the glycolytic flux in cultured rat astrocytes.

205754-33-2
DC10186 8-O-Acetyl shanzhiside methyl ester

8-O-Acetyl shanzhiside methyl ester (ND01) is an iridoid glucoside isolated from the leaves of Lamiophlomis rotata Kudo, a Chinese folk medicinal plant in Xi-zang.

57420-46-9
DC11964 Lys01

A 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ)..

391426-22-4
DC20669 Imexon

A 2-cyanoaziridine derivative with antitumor activity in some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma.

59643-91-3
DC23303 A 385358

A 385358 is a potent, selective, cell-permeable Bcl-XL inhibitor with Ki of 0.8 nM, displays >80-fold selectivity over Bcl-2 (Ki=64 nM).

406228-55-5
DC24006 Nucleoside-Analog-2

A 4′-azidocytidine analogue that shows anti-HCV activity..

876708-01-9
DC24009 Nucleoside-Analog-1

A 4′-azidocytidine analogue that shows anti-HCV activity..

876707-99-2
DC7038 A 922500 Featured

A 922500 is a potent, selective, and orally bioavailable DGAT-1 inhibitor with IC50 values of 7 nM and 24 nM for human and mouse DGAT-1 respectively.

959122-11-3
DC22355 Lisinopril

A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks..

76547-98-3
Page 6 / Total 1558 FirstPrevNextLastGoto